» Articles » PMID: 29366734

Left Ventricular Systolic Dysfunction Predicts Long-term Major Microvascular Complication Outcomes in Type 1 Diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study of Childhood Onset Diabetes

Overview
Specialty Endocrinology
Date 2018 Jan 26
PMID 29366734
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We aimed to assess association between abnormal LVEF, in the absence of coronary artery disease (CAD), and 25-year incidence of major outcomes of diabetes (MOD) in a cardiology substudy of the Pittsburgh Epidemiology of Diabetes Complications cohort of childhood-onset type 1 diabetes.

Methods: 115 normotensive type 1 diabetes individuals without known CAD, underwent a baseline exercise radionuclide ventriculography. Abnormal LVEF was defined as a resting ejection fraction <50% or a failure to increase ejection fraction with exercise by >5% (men) or a fall in ejection fraction with exercise (women). Cox proportional hazards models were used to predict the composite endpoint of MOD (first instance of major CAD, stroke, end-stage renal disease, blindness, amputation or diabetes-related death).

Results: Mean baseline age was 28 and diabetes duration 19 years. In a mean follow-up of 19 years, 50 MOD events were identified. Allowing for established risk factors at baseline, abnormal LVEF (n = 22) independently predicted MOD incidence (HR = 2.12, 95% CI: 1.12-4.00, p = 0.022) but not major CAD (HR = 1.33, 95% CI: 0.53-3.33, p = 0.539).

Conclusions: An abnormal LVEF may identify diabetic cardiomyopathy and predict long term risk of MOD (but not CAD alone) in type 1 diabetes individuals, consistent with it reflecting microvascular disease.

Citing Articles

Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.

Miller R, Orchard T, Costacou T Diabetes Res Clin Pract. 2020; 163:108141.

PMID: 32277955 PMC: 7269839. DOI: 10.1016/j.diabres.2020.108141.

References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
Boudina S, Abel E . Diabetic cardiomyopathy revisited. Circulation. 2007; 115(25):3213-23. DOI: 10.1161/CIRCULATIONAHA.106.679597. View

3.
Bonapace S, Rossi A, Lipari P, Bertolini L, Zenari L, Lanzoni L . Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes. J Diabetes Complications. 2015; 29(6):822-8. DOI: 10.1016/j.jdiacomp.2015.05.006. View

4.
Perseghin G, Lattuada G, De Cobelli F, Esposito A, Canu T, Ragogna F . Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications. Int J Cardiol. 2010; 154(2):111-5. DOI: 10.1016/j.ijcard.2010.09.010. View

5.
Brunvand L, Fugelseth D, Stensaeth K, Dahl-Jorgensen K, Margeirsdottir H . Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study. BMC Cardiovasc Disord. 2016; 16:103. PMC: 4881039. DOI: 10.1186/s12872-016-0288-1. View